Influence of delay on survival in patients with breast cancer: A systematic review

Lancet

Volumn 353, Issue 9159, 1999, Pages 1119-1126

  Richards, M A ^a   Westcombe, A M ^a   Love, S B ^a   Littlejohns, P ^b   Ramirez, A J ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SYMPTOM; TIME;

EID: 0033519039     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)02143-1     Document Type: Article

References (103)

1. Simmons C.C., Taylor G.W., Welch C.E. Carcinoma of the breast: end results, Massachusetts General Hospital, 1930, 1931 and 1932. Surg Gynecol Obstet. 69:1939;171-177.
2. Eggers C., de Cholnoky T., Jessup D. Cancer of the breast. Ann Surg. 113:1941;321-340.
3. Haagensen C., Stout A. Carcinoma of the breast I: results of treatment. Ann Surg. 116:1942;801-815.
4. Nohrman B. Cancer of the breast: clinical study of 1042 cases treated at Radiumhemmet between 1936 and 1941. Acta Radiol Suppl. 77:1949;1-98.
5. Eberbach C. Carcinoma of the breast. Wisconsin Med J. 48:1949;132-138.
6. Shimkin M., Eschecholtzia L., Stone R., Bell H. Cancer of the breast: analysis of frequency, distribution and mortality at the University of California Hospital. 1918-1947 inclusive. Surg Gynecol Obstet. 94:1952;645-661.
7. Harnett W. The relation between delay in treatment of cancer and survival rate. Br J Cancer. 7:1953;19-36.
8. Maclean W. Carcinoma of the breast: 10 year survey at Winnipeg General Hospital. J Intl Coll Surg. 20:1953;430-441.
9. Miller M., Prendergast E. Some observations concerned with carcinoma of the breast. Am J Roentgenol. 72:1954;942-952.
10. Robbins G., Bross I. The significance of delay in relation to prognosis of patients with primary operable breast cancer. Cancer. 10:1957;338-344.
11. Registrar General. Statistical review of England and Wales for the year 1952 (supplement on Cancer). London: HM Stationery Office, 1957.
12. Treves N., Holleb A. A report of 549 cases of breast cancer in women 35 years of age or younger. Surg Gynecol Obstet. 107:1958;271-283.
13. Waxman B., Fitts W. Survival of female patients with cancer of the breast. Am J Surg. 97:1959;31-35.
14. Anglem T., Gray E. Cancer of the breast and biological predeterminism: a re-evaluation. Cancer. 14:1961;1122-1126.
15. Lalanne C. Taux d'accroissement et prognostic des tumeurs malignes du sein. Acta Union Intl Contra Cancrum. 18:1962;807-814.
16. Rigby-Jones P. Prognosis of malignant tumours of the breast in relation to rate of growth and axillary lymph node involvement as observed clinically. Acta Union Intl Contra Cancrum. 18:1962;815-821.
17. Bloom H.J.G. The influence of delay on the natural history and prognosis of breast cancer: a study of cases followed for 5-20 years. Surgery. 12:1965;892-905.
18. DeVitt J. The clinical stages of breast cancer: what do they mean? Can Med Assoc J. 97:1967;1257-1262.
19. Registrar General. The Registrar General's statistical review of England and Wales for the year 1961: supplement on cancer. London: H M Stationery Office 1967.
20. Donegan W. Diagnosis in cancer of the breast. 1988.
21. Peltokallio P., Kalima T., Frilander M. Results of breast cancer treatment. Acta Chir Scand. 135:1969;585-590.
22. Sheridan B., Fleming J., Atkinson L., Scott G. The effects of delay in treatment on survival rates in carcinoma of the breast. Med J Aust. 1:1971;262-267.
23. Handley R. Observations and thoughts on cancer of the breast. Proc R Soc Med. 65:1972;437-444.
24. Pater J., Loeb M., Siu T. A multivariate analysis of the contribution of "auxonometry" to prognosis in breast cancer. J Chronic Dis. 32:1979;375-384.
25. Hermann R., Esselstyn C., Crile G., Cooperman A., Antunez A., Hoerr S. Results of conservative operations for breast cancer. Arch Surg. 120:1985;746-751.
26. Cummings K., Michalek A., Gregorio D., Walsh D. The effects of behavioral and biological factors on survival from breast cancer. Cancer Detect Prev. 6:1983;445-460.
27. Simmons C., Taylor G., Wallace R. Cancer of the breast: end results Massachusetts General Hospital, 1924, 1925 and 1926. N Engl J Med. 210:1934;836-844.
28. Shore B. Carcinoma of the breast: report of four hundred eighteen cases treated at St Luke's Hospital from 1922-1933. Surg Gynecol Obstet. 71:1940;515-519.
29. Hoopes B., McGraw A. The Halsted radical mastectomy: 5 year results in 246 consecutive operations at same clinic. Surgery. 12:1942;892-905.
30. Hawkins J. Evaluation of breast-cancer therapy as a guide to control programs. J Natl Cancer Inst. 4:1944;445-460.
31. Nicolson W., Grady E. Carcinoma of the breast. Ann Surg. 127:1948;992-1009.
32. Haagensen C., Stout A. Carcinoma of the breast: III results of treatment 1935-1942. Ann Surg. 134:1951;151-172.
33. Smithers D., Rigby-Jones P., Galton A., Payne P. Cancer of the breast: a review. Br J Radiol. 1952;1-90.
34. Macdonald I., Wilcox N. Prognosis of mammary carcinoma in young women. Cancer. 9:1956;281-289.
35. Moore C., Shaw H. Carcinoma of the breast: extent of original disease related to end results. Arch Surg. 75:1957;598-604.
36. White T. Breast cancer in women thirty years old or less. N W Med Seattle. 59:1960;218-220.
37. Berkson J. Prognosis of malignant tumours of the breast: a review of recent experiences of the Mayo clinic. Acta Union Intl Contra Cancrum. 18:1962;1003-1008.
38. Brinkley D., Haybittle J. A 15 year follow-up study of patients treated for carcinoma of the breast. Br J Radiol. 41:1968;215-221.
39. Wilkinson G.S., Edgerton F., Wallace H.J., Reese P., Patterson J., Priore R. Delay, stage of disease and survival from breast cancer. J Chronic Dis. 32:1979;365-373.
40. Elwood M., Moorehead W.P. Delay in diagnosis and long term survival in breast cancer. BMJ. 280:1980;1291-1294.
41. Dohrman P., Hughes E., McDermott F., Price A. Symptom duration, tumor staging and survival in patients with carcinoma of the breast. Surg Gynecol Obstet. 154:1982;707-710.
42. Feldman J. The effects of patient delay and symptoms other than a lump on survival in breast cancer. Cancer. 51:1983;1226-1229.
43. Charlson M. Delay in the treatment of carcinoma of the breast. Surg Gynecol Obstet. 160:1985;393-399.
44. Vernon S., Tilley B., Neale A., Steinfeldt L. Ethnicity, survival and delay in seeking treatment for symptoms of breast cancer. Cancer. 55:1985;1563-1571.
45. Huguley C., Brown R., Greenberg R., Clark W. Breast self-examination and survival from breast cancer. Cancer. 62:1988;1389-1396.
46. Neave L., Mason B., Kay R. Does delay in diagnosis of breast cancer affect survival? Breast Cancer Res Treat. 15:1990;103-108.
47. Crucitti F., Cinini C., Rossi S., Lombardo C., Bellantone R., Doglietto G. Early diagnosis of breast carcinoma:clinico-therapeutic and prognostic implications/la diagnosi precoce nel carcinoma della mammella. Implicazioni clinico-terapeutiche e prognostiche. Chirugia-Turin. 5/6:1992;357-360.
48. Rabinovich M., Vallejo C., Perez J.et al. Impact of delay to treatment upon survival in 1067 patients with breast cancer. Intl J Oncol. 2:1993;197-201.
49. Maguire A., Porta M., Malats N., Gallen M., Pinol J., Fernandez E. Cancer survival and the duration of symptoms: an analysis of possible forms for the risk of function. Eur J Cancer. 30A:1994;785-792.
50. Afzelius P., Zedeler K., Sommer H., Mouridsen H., Blichert-Toft M. Patient's and doctor's delay in primary breast cancer. Acta Oncol. 33:1994;345-351.
51. Raabe N., Fossaa S. Primary invasive breast carcinoma in Oslo 1980-1989: incidence and delay. Acta Oncol. 35:1996;9-15.
52. Alderson M., Hamlin I., Staunton M. The relative significance of prognostic factors in breast cancer. Br J Cancer. 25:1971;646-656.
53. Dennis C., Gardner B., Lim B. Analysis of survival and recurrence vs patient and doctor delay in treatment of breast cancer. Cancer. 35:1975;714-720.
54. Wallgren A., Silfersward C., Eklund G. Prognostic factors in mammary carcinoma. Acta Radiol. 15:1976;1-16.
55. Fisher E.R., Redmond C., Fisher B. A perspective concerning the relation of duration of symptoms to treatment failure in patients with breast cancer. Cancer. 40:1977;3160-3167.
56. Rubens R., Armitage P., Winter P., Tong D., Hayward J. Prognosis in inoperable stage III cancer of the breast. Eur J Cancer. 13:1977;805-811.
57. Hainsworth P., Henderson M., Bennett R. Delayed presentation in breast cancer: relationship to tumour stage and survival. Breast. 2:1993;37-41.
58. Goodwin J., Samet J., Hunt W. Determinants of survival in older cancer patients. J Natl Cancer Inst. 88:1996;1031-1038.
59. McWhirter R. Some factors influencing prognosis in breast cancer. J Fac Radiol. 8:1957;220-234.
60. MacKay E., Sellers A. Breast cancer at the Ontario cancer clinics 1938-1956: a statistical review. Can Med Assoc J. 92:1965;647-651.
61. Mausner J., Shimkin M., Moss N. Cancer of the breast in Philadelphia hospitals 1951-1964. Cancer. 23:1969;260-274.
62. Luff A. The incidence of cancer of the breast and its history after treatment. BMJ. 1:1932;897-903.
63. Greenough R., Taylor G. Cancer of the breast: end results - Massachusetts General Hospital 1921, 1922, 1923. N Engl J Med. 210:1934;831-835.
64. Davis H. Factors influencing prognosis in carcinoma of the breast. Ann Surg. 107:1938;207-217.
65. Hartmann H. The postoperative prognosis of cancer of the breast. New Intl Clin. 3:1941;78-87.
66. MacDonald I. Mammary carcinoma: a review of 2636 cases. Surg Gynecol Obstet. 74:1942;75-82.
67. Geschickter C. Diseases of the breast. 2nd:1945;JB Lippincott Co, Philadelphia.
68. Taylor G., Wallace R. Carcinoma of the breast, end results: Massachusetts General Hospital 1933-1935. N Engl J Med. 237:1947;475-477.
69. Kreyberg L., Christiansen T. The prognostic significance of small size in breast cancer. Br J Cancer. 7:1953;37-44.
70. Rennaes S. Cancer of the breast in women: a clinical and statistical investigation of the material at the Norwegian Radium Hospital 1932-1951. Acta Chir Scand. 266(suppl):1960;7-102.
71. Brightmore T., Greening W., Hamlin I. An analysis of clinical and histopathological features in 101 cases of carcinoma of breast in women under 35 years of age. Br J Cancer. 24:1970;644-669.
72. Greenough R., Simmons C., Barney J. The results of operations for cancer of the breast at the Massachusetts General Hospital from 1894 to 1904. Surg Gynecol Obstet. 5:1907;39-50.
73. Davis B. Operative results in two hundred breast tumors. Ann Surg. 71:1920;270-275.
74. Greenough R. Cancer of the breast at the Massachusetts General Hospital, 1918, 1919, 1920. South Med J. 18:1925;187-192.
75. Buchanan J. End results in amputation of the breast for cancer. Atlantic Med J. xxxi:1928;634-706.
76. Wevill L. Malignant disease of the breast: a statistical survey of 1000 case records. Edinburgh Med J. 39:1932;714-737.
77. Nathanson I., Welch C. Life expectancy and incidence ofmalignant disease: carcinoma of the breast. Am J Cancer. 28:1936;40-53.
78. Kunath C. Problem of cancer of the breast: radical mastectomy in 90 cases. Arch Surg. 41:1940;66-78.
79. Delario A. Breast cancer: factors modifying prognosis. New York: Macmillan, 1959: 123-135.
80. Humphrey L., Swerdlow M. Factors influencing the survival ofpatients with carcinoma of the breast. Am J Surg. 106:1963;440-444.
81. Elmendorff H., Heyers H., Neugebauer W. Delay of operation and survival of cancer patients. Langenbecks Arch Surg. 328:1971;169-179.
82. Ariel I. Results of treating 1178 patients with breast cancer by radical mastectomy and postoperative irradiation where metastases to axillary lymph nodes occurred. J Surg Oncol. 12:1979;137-153.
83. Black C., Morris D., Goldman L., McDonald J. The significnace of lymph node involvement in patients with medullary carcinoma of the breast. Surg Gynecol Obstet. 157:1983;497-499.
84. Saario I., Leivonen M., Tolppanen E., Kalima T., Appelqvist P., Salmo M. Changes in the treatment and prognosis of breast cancer. Ann Chir Gynaecol. 75:1986;254-259.
85. Nagadowska M., Kulakowski A. Breast cancer in elderly women: characteristics of the disease. Eur J Surg Oncol. 17:1991;609-614.
86. Norum J., Wist E. Delay in diagnosis and treatment of breast cancer in northern Norway. Oncol Rep. 3:1996;571-574.
87. Office of Population Census and Surveys. Cancer statistics: registrations, series MB1 no 21. London: HM Stationery Office, 1994.
88. Scottish Health Service. Scottish health statistics. Edinburgh: Information and Statistics Division, Common Services Agency, 1996.
89. Richards M.A., Smith P., Ramirez A.J., Fentiman I.S., Rubens R.D. The influence on survival of delay in presentation and treatment of symptomatic breast cancer. Br J Cancer. 79:1999;858-864.
90. Quinn M., Allen E. Changes in incidence of an mortality from breast cancer in England and Wales since introduction of screening. BMJ. 311:1995;1391-1395.
91. Beral V., Hermon C., Reeves G., Peto R. Sudden fall in breast cancer death rated in England and Wales. Lancet. 345:1995;1641-1643.
92. Peto R. Mortality from breast cancer in UK has decreased suddenly. BMJ. 317:1998;476-477.
93. Richards M.A., Westcombe A.M., Ramirez A.J., et al. A systematic review of the delay in diagnosis/treatment of symptomatic breast cancer, 1999: a report commissioned by the NHS Cancer Research and Development Programme. 1999 (in press).
94. Ramirez A.J., Westcombe A.M., Burgess C.C.et al. Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet. 353:1999;1127-1131.
95. Oxman A. Checklists for review articles. BMJ. 309:1994;648-651.
96. Deeks J., Glanville J., Sheldon T. Undertaking systematic reviews of research on effectiveness: CRD guidelines for those carrying out or commissioning reviews - CRD report 4. York: University of York, 1996.
97. Delgado D., Lin W., Coffey M. The role of Hispanic race/ethnicity and poverty in breast cancer survival. Puerto Rico Health Sci J. 14:1995;103-116.
98. Early Breast Cancer Trialists' Collaborative Group. Systematic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992; 339: 1-15, 71-85.
99. Reducing diagnostic delay in breast cancer: possible therapeutic implications. Cancer. 58:1986;1756-1761.
100. Richardson J.B.L., Bernstein C., Burciaga C., Danley R., Ross R. Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer. 65:1992;922-926.
101. Burgess C., Ramirez A., Richards M., Love S. Who and whatinfluences delayed presentation in breast cancer? Br J Cancer. 77:1998;1343-1348.
102. Secretary of State for Health. The new NHS, modern, dependable. London: Stationery Office, 1997.
103. National Cancer Alliance. Patient-centred cancer services? What patients say. London: National Cancer Alliance, 1996.